Abstract:To investigate the distribution and drug resistance of pathogenic bacteria in neonatal respiratory tract bacterial infections in Yulin from 2017 to 2019. MethodsA total of 1 594 neonates with respiratory tract infection from 7 hospitals in Yulin from 2019 to 2021 were selected as the research object, which sputum samples were collected and monitored for bacterial distribution and drug resistance. ResultsA total of 1 400 strains of pathogenic bacteria (87.83%) were isolated, the top five pathogens were Klebsiella pneumoniae, Escherichia coli, Acinetobacter baumannii, Staphylococcus aureus, and Pseudomonas aeruginosa. 688 strains of multidrug-resistant bacteria were detected, and the top three were extended-spectrum β-lactamase (ESBLS)-producing Klebsiella pneumoniae, carbapenem-resistant Acinetobacter baumannii, and ESBLS-producing Escherichia coli. ESBLS-producing Klebsiella pneumoniae is sensitive to tobramycin, and levofloxacin. Carbapene-resistant Acinetobacter baumannii is sensitive to tigecycline and akamicin. ConclusionThe pathogenic bacteria of neonatal respiratory tract infection are mainly gram-negative bacteria and the multi-drug resistant bacteria were mainly ESBLS-producing.